The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis: a dose-finding phase-II-study
Liver cirrhosis, phosphodiesterase-5-inhibitors, portal hypertension, portal pressure, udenafil
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
Februar 2015
|
| In: |
Digestive and liver disease
Year: 2015, Volume: 47, Issue: 2, Pages: 144-50 |
| ISSN: | 1878-3562 |
| Online Access: | Verlag, Volltext: http://ac.els-cdn.com/S1590865814007634/1-s2.0-S1590865814007634-main.pdf?_tid=fc46040a-d0c9-11e5-98ab-00000aacb360&acdnat=1455200344_f33322a8652caa31b3ab9406703908dc |
| Author Notes: | Wolfgang Kreisel, Peter Deibert, Limas Kupcinskas, Jolanta Sumskiene, Beate Appenrodt, Susanne Roth, Michaela Neagu, Martin Rössle, Alexander Zipprich, Karel Caca, Arnulf Ferlitsch, Karin Dilger, Ralf Mohrbacher, Roland Greinwald, Tilman Sauerbruch |
| Summary: | Liver cirrhosis, phosphodiesterase-5-inhibitors, portal hypertension, portal pressure, udenafil |
|---|---|
| Physical Description: | Online Resource |
| ISSN: | 1878-3562 |